Yousif Capital Management LLC Lowers Stock Position in Humana Inc. (NYSE:HUM)

Yousif Capital Management LLC decreased its position in Humana Inc. (NYSE:HUM) by 0.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,049 shares of the insurance provider’s stock after selling 160 shares during the period. Yousif Capital Management LLC’s holdings in Humana were worth $5,340,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. State Street Corp increased its stake in shares of Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock valued at $1,701,582,000 after purchasing an additional 53,272 shares in the last quarter. FMR LLC grew its holdings in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the period. Pzena Investment Management LLC increased its position in shares of Humana by 8.1% in the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after buying an additional 187,903 shares in the last quarter. Ontario Teachers Pension Plan Board raised its stake in shares of Humana by 6.5% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after buying an additional 71,910 shares during the period. Finally, Sanders Capital LLC lifted its position in shares of Humana by 1.0% during the 3rd quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock valued at $370,060,000 after buying an additional 11,923 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

HUM has been the subject of a number of research analyst reports. TD Cowen upped their price objective on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Piper Sandler upped their price target on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Wells Fargo & Company decreased their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and boosted their price objective for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, Barclays raised their target price on Humana from $253.00 to $255.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 22nd. Nineteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Humana presently has a consensus rating of “Hold” and an average price target of $297.68.

Humana Stock Performance

NYSE HUM opened at $279.63 on Friday. The stock has a fifty day simple moving average of $275.01 and a 200-day simple moving average of $299.65. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market cap of $33.67 billion, a PE ratio of 24.77, a P/E/G ratio of 2.21 and a beta of 0.56. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.32% of the stock is currently owned by corporate insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.